www.clovisoncology.com
Open in
urlscan Pro
104.130.135.23
Public Scan
Submitted URL: http://www.clovisoncology.com/
Effective URL: https://www.clovisoncology.com/
Submission: On October 17 via api from US — Scanned from DE
Effective URL: https://www.clovisoncology.com/
Submission: On October 17 via api from US — Scanned from DE
Form analysis
1 forms found in the DOM/search/
<form action="/search/">
<input name="q" type="text">
<button type="submit" value="Search"></button>
</form>
Text Content
Contact Us Locations Menu * About * About Us * Mission * Leadership * Transparency Reporting * Products * Pipeline * Pipeline Overview * Rucaparib * FAP-2286 * Lucitanib * Scientific Presentations * Clinical Trials * Compassionate Use * Partnering * Patients * Clinical Trials * Patient Advocacy * Patient Access * Investors & News * Careers * Contact Us * Locations CANCER CAN’T keep us from finding solutions. Learn More CANCER CAN’T keep me from living my life. Learn More CANCER CAN'T outrun my research forever. Learn More CANCER CAN’T keep us from finding solutions. Learn More CANCER CAN’T keep me from living my life. Learn More * 1 * 2 * 3 ADVANCING THE FIGHT AGAINST CANCER In our pursuit to improve the lives of people living with cancer, Clovis Oncology is committed to realizing the promise of precision medicine for cancer. We seek to develop targeted therapies to better serve patients and ensure the right drug gets to the right patient. Learn More LATEST NEWS CLOVIS ONCOLOGY HIGHLIGHTS UPDATED LUMIERE PHASE 1 DATA OF TARGETED RADIOTHERAPY CANDIDATE FAP-2286 AT THE 35TH ANNUAL EANM CONGRESS Updated LuMIERE Phase 1 data demonstrated a manageable safety profile with some preliminary evidence... Read More TRITON3 PHASE 3 TRIAL OF RUBRACA® (RUCAPARIB) ACHIEVES PRIMARY ENDPOINT IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WITH BRCA OR ATM MUTATIONS TRITON3 study evaluating Rubraca monotherapy versus chemotherapy or second-line androgen deprivation... Read More JOIN US Help us develop cutting-edge treatments Learn More INVESTORS Investment information & stock performance Learn More EVENTS View our upcoming events and presentations Learn More * About * Pipeline * Partnering * Patients * Investors & News * Careers * Contact Us * Privacy Policy * Cookie Policy * Terms * Sitemap Copyright © 2022 BY CLOVIS ONCOLOGY, ALL RIGHTS RESERVED. This website uses cookies to improve your overall experience. By using this website without changing your cookie settings, you agree to our use of cookies. For more information on how we use cookies, please see our Cookie Policy and Privacy Policy. By clicking Accept you consent to our use of cookies. Accept